The Hartford Healthcare Fund Class R4 (HGHSX)
| Fund Assets | 837.48M |
| Expense Ratio | 1.31% |
| Min. Investment | $0.00 |
| Turnover | 40.00% |
| Dividend (ttm) | 1.90 |
| Dividend Yield | 4.39% |
| Dividend Growth | -26.10% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 11, 2025 |
| Previous Close | 41.86 |
| YTD Return | -4.23% |
| 1-Year Return | 12.02% |
| 5-Year Return | 11.96% |
| 52-Week Low | 35.08 |
| 52-Week High | 45.73 |
| Beta (5Y) | n/a |
| Holdings | 88 |
| Inception Date | Dec 22, 2006 |
About HGHSX
The Hartford Mutual Funds, Inc.: Hartford Healthcare Fund; Class R4 Shares is an open-end mutual fund that targets long-term capital appreciation by investing primarily in the global health care sector. Its strategy is to allocate at least 80% of assets to equity securities of companies connected to health care industries, including pharmaceuticals, biotechnology, medical products, services, and health care delivery. The fund is sub-advised by Wellington Management Company LLP, leveraging in-depth research to identify high-conviction investment opportunities and capitalize on demographic shifts, globalization, and innovation trends within the health care market. It typically holds 85–100 securities and focuses heavily on U.S.-based firms, with a modest allocation to foreign equities. The R4 share class is designed to be accessible, featuring no minimum investment requirement for standard taxable accounts and an expense ratio around 1.3%. Notable for its annual dividend distribution and a competitive yield, the fund provides investors with targeted exposure to a vital and evolving sector that is integral to global economies and public well-being.
Performance
HGHSX had a total return of 12.02% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.27%.
Top 10 Holdings
47.71% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 13.16% |
| Merck & Co., Inc. | MRK | 5.76% |
| Johnson & Johnson | JNJ | 5.09% |
| UnitedHealth Group Incorporated | UNH | 4.66% |
| AbbVie Inc. | ABBV | 3.86% |
| Intuitive Surgical, Inc. | ISRG | 3.52% |
| Danaher Corporation | DHR | 3.07% |
| Abbott Laboratories | ABT | 3.07% |
| Edwards Lifesciences Corporation | EW | 2.84% |
| Cencora, Inc. | COR | 2.68% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 11, 2025 | $1.40315 | Dec 12, 2025 |
| Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
| Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
| Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
| Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
| Dec 10, 2019 | $2.36232 | Dec 11, 2019 |